Monash University and Seaport Therapeutics have developed a new approach to delivering drug molecules that piggybacks onto ...
Advances in Bladder Cancer: innovation in diagnostics, therapeutic technology, and clinical pathways
Non–muscle-invasive bladder cancer (NMIBC) and muscle-invasive bladder cancer (MIBC) continue to pose significant clinical and health-economic challenges in ...
Clinical Skills Institute expands its $900 online medical assistant program, preparing students for the NHA CCMA exam ...
Navigator models, particularly cross-specialty nurse navigation, reduce stress, expedite diagnosis-to-treatment transitions, ...
Artelo Biosciences Expands ART27.13 Development as a Potential Companion Therapy to GLP-1 Treatments
Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling ...
The initiative offers student loan repayment to nursing & therapy graduates and to current employees, including ...
Regulatory review timelines shifted from March 29 to June 29, 2026, after FDA requested more time to assess CMC/manufacturing ...
YouTube on MSNOpinion
Edward MR Macfarlane: Designing integrated veteran healthcare pathways
Edward M.R. Macfarlane’s weServed™ platform creates a unified digital ecosystem to bridge gaps between the NHS, charities, ...
Understand the signs of premature ovarian failure and POI. Learn how to manage symptoms and protect your long-term health.
COMP360 is the first classic psychedelic1 to consistently achieve a highly statistically significant result and clinically meaningful effect in treatment resistant depression (TRD), with a generally ...
The trial will compare the safety and efficacy of equecabtagene autoleucel versus standard therapies in r/r MM patients.
The post HYD Pioneers New Research Revealing Systemic Role of Deuterium-Depleted Water in Cancer Therapy appeared first on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results